News
12-08-2011, 05:12 AM
Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were treated with dose-dense chemotherapy and the bisphosphonate ibandronate. Volker Möbus, Ph.D...
More... (http://www.medicalnewstoday.com/releases/238849.php)
More... (http://www.medicalnewstoday.com/releases/238849.php)